Wang XL et al. |
Inhibition of ATP binding to the carboxyl terminus of Kir6.2 by epoxyeicosatrienoic acids. |
2006 |
Biochim. Biophys. Acta |
pmid:16904368
|
Wei S et al. |
Chiral resolution of the epoxyeicosatrienoic acids, arachidonic acid epoxygenase metabolites. |
2006 |
Anal. Biochem. |
pmid:16480681
|
Morin C and Rousseau E |
Effects of 5-oxo-ETE and 14,15-EET on reactivity and Ca2+ sensitivity in guinea pig bronchi. |
2007 |
Prostaglandins Other Lipid Mediat. |
pmid:17164130
|
Jiang JG et al. |
Regulation of endothelial nitric-oxide synthase activity through phosphorylation in response to epoxyeicosatrienoic acids. |
2007 |
Prostaglandins Other Lipid Mediat. |
pmid:17164144
|
Morin C et al. |
Epoxyeicosatrienoic acid relaxing effects involve Ca2+-activated K+ channel activation and CPI-17 dephosphorylation in human bronchi. |
2007 |
Am. J. Respir. Cell Mol. Biol. |
pmid:17237191
|
Gross GJ et al. |
Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. |
2007 |
J. Mol. Cell. Cardiol. |
pmid:17217955
|
Chen J et al. |
Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite. |
2007 |
Mol. Cell. Biol. |
pmid:17283047
|
Koerner IP et al. |
Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. |
2007 |
J. Neurosci. |
pmid:17460077
|
Yang W et al. |
Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17327488
|
Motoki A et al. |
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18835921
|
Terashvili M et al. |
Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18492947
|
Smith HE et al. |
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. |
2008 |
Pharmacogenet. Genomics |
pmid:18769365
|
Snider NT et al. |
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18698000
|
Morin C et al. |
CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi. |
2008 |
Am. J. Respir. Cell Mol. Biol. |
pmid:18757304
|
Morin C et al. |
EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17. |
2008 |
Am. J. Respir. Cell Mol. Biol. |
pmid:17872494
|
Michaelis UR et al. |
Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells. |
2008 |
Invest. Ophthalmol. Vis. Sci. |
pmid:18326754
|
Ghosh S et al. |
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. |
2008 |
Basic Clin. Pharmacol. Toxicol. |
pmid:18312493
|
Gross GJ et al. |
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18441205
|
Cheranov SY et al. |
An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. |
2008 |
Blood |
pmid:18408167
|
Chen Y et al. |
20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site. |
2009 |
J. Pharmacol. Exp. Ther. |
pmid:19762546
|